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ORIGINAL RESEARCH
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Emission Tomography
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Søren Just Christensen, MD,2 Peter Rasmussen, PhD,2
Niels Vidiendal Olsen, MD, DMSc,2,3 Ian Law, MD, DMSc,4,5
Henrik Bo Wiberg Larsson, MD, DMSc,1,4 and Otto Mølby Henriksen, MD, PhD5
Purpose: To compare mean global cerebral blood flow (CBF) measured by phase-contrast mapping magnetic resonance
imaging (PCM MRI) and by 15O-H2O positron emission tomography (PET) in healthy subjects. PCM MRI is increasingly
being used to measure mean global CBF, but has not been validated in vivo against an accepted reference technique.
Materials and Methods: Same-day measurements of CBF by 15O-H2O PET and subsequently by PCM MRI were per-
formed on 22 healthy young male volunteers. Global CBF by PET was determined by applying a one-tissue compart-
ment model with measurement of the arterial input function. Flow was measured in the internal carotid and vertebral
arteries by a noncardiac triggered PCM MRI sequence at 3T. The measured flow was normalized to total brain weight
determined from a volume-segmented 3D T1-weighted anatomical MR-scan.
Results: Mean CBF was 34.963.4mL/100 g/min measured by 15O-H2O PET and 57.066.8mL/100 g/min measured by PCM
MRI. The measurements were highly correlated (P5 0.0008, R25 0.44), although values obtained by PCM MRI were higher
compared to 15O-H2O PET (absolute and relative differences were 22.06 5.2 mL/100 g/min and 63.4614.8%, respectively).
Conclusion: This study confirms the use of PCM MRI for quantification of global CBF, but also that PCM MRI systemati-
cally yields higher values relative to 15O-H2O PET, probably related to methodological bias.
Level of Evidence: 1
J. MAGN. RESON. IMAGING 2017;45:692–699
Measurement of cerebral blood flow (CBF) is of inter-est, both in the clinical setting and for research. Abso-
lute quantification of global CBF is of key importance when
investigating factors affecting the entire brain, eg, altered
physiological states or aging.1–3
Different invasive and noninvasive methods have been
used to measure global CBF.4,5 Phase-contrast mapping (PCM)
magnetic resonance imaging (MRI) allows measurement of total
flow in the cerebral arteries, and calculation of global CBF by
subsequently normalizing to brain volume.6 Measurement of
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global CBF by PCM MRI has a number of advantages com-
pared to other techniques. It is completely noninvasive, fast,
and can be combined with other noninvasive MRI techniques
for absolute quantification of global cerebral metabolic rate of
oxygen7,8 or be used for scaling of regional CBF measured by
arterial spin labeling.9,10 The technique has been used in a
number of studies on variation in CBF in healthy individu-
als11,12 and in larger population-based studies of aging showing
that global CBF decreases with age and that decreased global
CBF is associated with accelerated signs of brain aging and
increased all-cause mortality.2,3,6,13–15
Values of global CBF obtained by PCM MRI in
healthy subjects6,16 are generally in good agreement with
accepted textbook CBF values of 50mL/100 g/min.17,18
Previous studies have also shown excellent reproducibility
for CBF measurements in vivo12,16, and shown PCM MRI
to be accurate for measuring flow in phantoms19 and in
large vessels.20
In order to confidently interpret the physiological sig-
nificance of these measurements, in vivo validation of the
accuracy of PCM MRI for CBF measurements is required.
However, comparative studies with accepted reference meth-
ods are generally lacking. For human studies, 15O-H2O pos-
itron emission tomography (PET) is generally considered
the best available method for absolute CBF measure-
ments.9,21–24 One previous study failed to show a correla-
tion of CBF measured by PCM MRI and 15O-H2O PET,
but these measurements were obtained months apart and
did not account for a number of important physiological
covariates.16
The aim of the present study was to validate PCM
MRI for measurement of global CBF by same-day measure-
ments of global CBF by PCM MRI and 15O-H2O PET.
Materials and Methods
Twenty-two healthy males (mean age: 27.4 years, range: 18–40
years) participated in the study. The measurements were obtained
as a part of a placebo-controlled, crossover study investigating the
effect of erythropoietin on cerebral metabolism. Measurements
from PCM MRI have previously been published.8 In the present
analysis only data during placebo treatment are included.
The study was approved by the Danish National Committee
on Health Research Ethics (H-4-2012-167) and was conducted
according to the Declaration of Helsinki. Written informed con-
sent was obtained from all participants.
General Experimental Setup
All experimental measurements in each subject were performed on
the same day. Height and weight were measured at the time of
inclusion in the study. After an overnight fast, a short catheter was
inserted in the radial artery of the nondominant hand for blood
sampling. After the 15O-H2O PET scans, the subjects had a small
meal before being transported to the MRI facility. The PET and
MRI scans were performed 2–6 hours apart.
Before the PET scans a venous blood sample was obtained
and analyzed for hemoglobin. Arterial blood samples were obtained
between the two PET scans and again after the MRI CBF measure-
ment, and analyzed for oxygen saturation (SaO2), and partial pres-
sures of O2 (PaO2) and of CO2 (PaCO2) using a Radiometer
ABL800 Flex system (Radiometer, Copenhagen, Denmark). The
arterial blood sample obtained at the MRI session was also ana-
lyzed for hemoglobin.
PET
PET scans were performed on a Siemens High Resolution Research
Tomograph (HRRT) brain PET scanner (Siemens, Knoxville,
TN).25,26 The scanner had an axial field of view of 25 cm and a
near isotropic resolution of 2mm. During PET scanning the sub-
ject’s head rested in a foam-cushioned headrest, and a head strap
was used to minimize head movement. Initially, a 6-minute trans-
mission scan with a rotating 137Cs single-photon point source was
performed for attenuation correction.
Approximately 800MBq of 15O radiolabeled water (half-life:
123 sec) produced online was injected as a bolus using an Auto-
matic Water Injection System (Scansys Laboratorieteknik, Værløse,
Denmark).
Arterial blood sampling was initiated 15 seconds before iso-
tope injection. Emission scans were acquired after injection of
intravenous bolus of tracer for 7 minutes in dynamic frames of 1
3 30 seconds, 18 3 5 seconds, 9 3 10 seconds, 10 3 15 seconds,
and 2 3 30 seconds. Radioactivity concentration in the arterial
blood was continuously measured by an automatic blood sampling
system and drawn at 8mL/min (Allogg ABSS, Mariefred, Sweden).
The detectors in the system were cross-calibrated against the PET
scanner and the sampling frequency was 2Hz. The inner diameter
of the tube connected to the arterial catheter was 1.2mm. The
clocks of the scanner and sampling system were synchronized.
Two consecutive scans were acquired for each subject with
an interval of at least 10 minutes between the two injections to
allow for washout and isotope decay.
Scans were reconstructed using 3D-ordered subset expecta-
tion maximum and point spread function (3D OSEM-PSF).27
Each map consisted of 207 image planes in a 256 3 256 matrix
with an isotropic voxel size of 1.22 3 1.22 3 1.22mm3. All
images were corrected for randoms, scatter, attenuation (TXTV
method),28 decay and dead time, and filtered with a 3D Gaussian
5mm filter.
Postprocessing
Quantitative regional CBF-maps were calculated using a 1-tissue 2-
compartment model:
dCtðtÞ
dt
5K1CaðtÞ2k2CtðtÞ (1)
where Ct is the tissue compartment concentration, Ca is the arterial
concentration, K1 is the influx rate constant, which describes the
unidirectional clearance of water from the blood to the tissue in
mL/100 g/min, scaled to perfusion by a factor of one when assum-
ing full extraction of water, and k2 is the efflux rate constant (in
min21). The model also accounts for the contribution to the
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measured voxel concentration Ctot from the vascular volume com-
ponent vB:
CtotðtÞ5ð12vBÞCtðtÞ1vBCaðtÞ (2)
where Ctot is the measured tissue time activity and vB is the blood
volume fraction.
The parametric maps were calculated using linear ridge
regression with a spatial constraint parameter to increase signal-to-
noise ratio (SNR), as described by Zhou et al.29 The arterial input
curves used in modeling were corrected for dead-time, decay, delay,
and dispersion. The calculation was done using the software
PMOD 3.0 (PMOD Technologies, Z€urich, Switzerland).
Using the software PVElab,30 each regional CBF-map was
coregistered to the volume segmented brain tissue mask from the
3D T1-weighted anatomical MR-scan (Fig. 1), and global CBF
was calculated as the mean of all brain voxels.
MRI
FLOW MEASUREMENT. MR scans were performed on a 3T Phi-
lips Achieva MRI scanner (Philips Medical Systems, Best, The
Netherlands) using a 32-channel phase array head coil. The blood
velocity in the carotid and vertebral arteries were measured using a
through-plane phase-encoding technique.
The sequence acquires a reference phase image and a velocity
sensitive phase image by using a bipolar gradient in the slice-
selection direction. By subtracting the velocity sensitive phase
image with the reference phase image, a phase-contrast map is cal-
culated. The phase-contrast maps can be scaled to velocity accord-
ing to the velocity-encoding factor (Venc).
Based on an initial 2D inflow angiogram, the measurement
slice was positioned orthogonal to the carotid and vertebral arteries
(Fig. 2a). The imaging parameters for the sequence were: field of
view (FOV)5 240 3 240mm2, voxel size5 0.75 3 0.75 3
8mm3, 1 slice, TE5 7.33 msec, TR5 27.63 msec, flip angle5 108,
10 repeated measures, and total scan time5 1 minute 42 seconds.
In order to reduce scan time, cardiac triggering was not applied.
When acquiring PCM MRI without cardiac triggering, the k-space
is random-sampled in an interval including multiple cardiac cycles
causing time averaging of the velocity.19,31 A Venc of 100 cm/s was
applied in order to avoid underestimation of flow velocities due to
aliasing of the phase at high velocities. When performing measure-
ments without cardiac triggering, potential aliasing from high veloci-
ties is not clearly visible because the average velocity is measured.
FIGURE 1: Fusion and segmentation of structural MRI and CBF PET maps. The brain extracted 3D T1-weighted structural MRI scan
(a) was segmented into gray and white matter using FSL FAST (b) and coregistered to the CBF PET map (c) of the subject using
PVElab software (d). Mean global CBF was calculated as the average of all brain voxels. Note spill-out of PET signal not covered
by the brain mask on the fused image.
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The Venc was therefore chosen around the upper normal peak veloci-
ty values in the internal carotid and vertebral arteries in young sub-
jects while maintaining a reasonable dynamic range.32
POSTPROCESSING. The total flow was calculated by measuring
the mean velocity and the cross-sectional area of the cerebral
arteries by drawing regions of interests (ROI) corresponding to
each cerebral artery (Fig. 2b). The ROIs were initially drawn man-
ually on the magnitude image of the first measurement and then
copied to the corresponding velocity map. Only voxels with a posi-
tive mean velocity were included. ROIs were subsequently copied
to the following measurements and inspected for misalignment
from possible motion and corrected by moving the ROI if neces-
sary. Cross-sectional area and diameter of the cerebral arteries were
calculated from the ROIs. Flow was calculated for each measure-
ment by multiplying mean velocity with the cross-sectional area
and integrating over time. The total flow of the four arteries was
normalized to whole-brain tissue weight to attain quantitative
physiological global CBF values in mL/100 g/min. For comparison
with PET, the average of all 10 measurements was used.
ANATOMICAL SCAN. An anatomical scan for segmenting brain
tissue was obtained with a 3D T1-weighted turbo field echo
sequence (FOV5 241 3 180 3 165mm3, voxel size5 1.09 3
0.81 3 1.1mm3, TE5 2.78 msec, TR5 6.9 msec, flip angle5 98).
The FSL BET and FAST tools (FMRIB Software Library,
Oxford University, Oxford, UK)33 were used to produce a whole-brain
tissue mask including cerebral hemispheres (excluding the ventricles),
cerebellum, and the brainstem. The mask was inspected (by coauthor
M.B.V.) and manually edited if necessary. The same brain volume
mask was used for segmentation of the PET scan and for calculation
of brain weight assuming a brain tissue density of 1.05 g/mL.34
Statistics
For comparison of CBF values, the mean of the 10 repeated PCM
MRI measurements and of the two PET scans were used. A paired
t-test was used to compare mean values of measurements from
PET and MRI. Agreement was assessed by linear regression and
calculation of Pearson’s correlation coefficient (R2), and by Bland–
Altman analysis. Both absolute (CBFPCM – CBFPET) and relative
([CBFPCM – CBFPET]/ CBFPET) differences were calculated.
As spontaneous fluctuations in PaCO2 have been shown to
introduce within-subject variability of CBF measurements,35,36 the
possible influence of PaCO2 fluctuations were investigated by
including the difference in PaCO2 (PaCO2PCM – PaCO2PET) as a
covariate in a multiple regression model with CBFPCM as the
dependent variable and CBFPET as the independent variable.
Method precision was assessed as the intrasubject variability
derived from a mixed linear model including all repeated measure-
ments of global CBF by each method. Subject was entered as random
effect and measurement number as fixed effect in the model. From
the mixed linear model within-subject and between-subject variance
can be separated. The corresponding within-subject and between-
subject coefficients of variation were calculated as the respective stan-
dard deviations divided by the mean value of the measurements.
Except where indicated otherwise, all results are reported as
mean6 standard deviation.
Results
Results of mean velocity, vessel cross-sectional area, and
diameter from PCM measurements are presented in Table
1. Physiological measurements at the two sessions, and brain
and body size of participants, are shown in Table 2.
FIGURE 2: Phase-contrast measurements. (a) Example of lateral
and anteroposterior maximal intensity projections of the carot-
id and vertebral arteries with the imaging plane visualized. (b)
Example of velocity map measurement perpendicular to the
carotids and vertebral arteries. The four arteries are clearly visi-
ble. In the lower panel examples of regions of interest (white
contours) of the left (c) and right (d) carotid and vertebral
arteries are demonstrated.
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Mean global CBF was on average 34.96 3.4mL/100 g/
min using 15O-H2O PET and 57.06 6.8mL/100 g/min using
PCM MRI. Absolute and relative differences between 15O-
H2O PET and PCM MRI were 22.06 5.2mL/100 g/min
and 63.46 14.8%, respectively (P < 0.0001 for difference).
Linear regression (Fig. 3a) showed a highly significant
positive correlation of PCM MRI and 15O-H2O PET
(P5 0.0008, R25 0.44). The slope of the regression was higher
than one, indicating that the difference between the methods
was perfusion-dependent and increased with higher perfusion
values. The positive slope of the regression line in the Bland–
Altman plot (Fig. 3b) was significantly different from zero
(P5 0.0014), confirming a systematic perfusion-dependent dif-
ference between CBF values obtained by the two methods.
When including PaCO2 difference in the linear model,
the effect of PaCO2 difference was near-significantly correlated
with PCM CBF (95% confidence interval5 [–0.58;10.4],
P5 0.077) and R2 increased to 0.53. When comparing the
models with and without CO2-difference by F-test the
improvement in fit was shown to be nonsignificant
(P5 0.091).
Intrasubject variability of global CBF was 6.5%
using PCM MRI and 5.7% using PET. The corresponding
values of intersubject variability were 11.6% and 8.6%,
respectively.
Discussion
The present study compared global CBF values obtained by
MRI using PCM and by PETusing 15O-H2O in healthy volun-
teers. The main finding is that global CBF obtained by PCM
MRI is highly correlated with values obtained by 15O-H152 O
PET, thereby confirming the ability of PCM MRI to obtain
quantitative measures of global CBF. However, the analysis also
demonstrated a systematic relative perfusion-dependent differ-
ence between CBF values obtained by the two methods.
The average mean CBF values obtained by the two
methods differed in opposite directions from the generally
accepted textbook normal global CBF values of 46–50mL/
100 g/min.17,18 Nevertheless, the values obtained by each
method were very similar to those previously reported in
healthy subjects,12,16,37 indicating that the differences more
likely reflect general methodological biases rather than the
current implementation of the methods or data processing.
The PCM MRI technique has some well-known errors
and limitations, primarily related to the limited resolution
and the suboptimal measurement geometry of the PCM MRI
measurements. First of all, voxels in the periphery of the vessel
will contain signal from moving and stationary tissue, causing
an underestimation of velocity and overestimation of the cross-
sectional area of the vessel. The result of these two opposite
effects on flow quantitation has in simulation studies been
TABLE 1. Results of Phase-Contrast Mapping Measurements
Flow [mL/min] Flow fraction [%]a Velocity [cm/s] Area [mm2] Diameter [voxels]b
Right ICA 293.1 6 53.7 35.4 6 2.4 21.0 6 3.1 23.6 6 4.3 7.3 6 0.8
Left ICA 292.2 6 42.0 35.5 6 2.1 21.0 6 2.5 23.4 6 4.0 7.1 6 0.9
Right VA 102.5 6 45.9 12.4 6 4.8 12.4 6 2.2 13.5 6 4.7 5.3 6 1.0
Left VA 135.5 6 40.5 16.7 6 4.8 13.8 6 2.4 16.5 6 5.0 5.9 6 0.8
Total 823.3 6 112.4
aPercentage of total flow, bnarrowest diameter. ICA, internal carotid artery; VA, vertebral artery.
TABLE 2. Physiological Measurements and Brain and Body Size
15O-H2O PET PCM MRI P-value for
difference
SaO2 [%] 98.3 6 0.3 98.1 6 0.5 0.04
PaO2 [kPa] 15.6 6 1.0 14.2 6 1.3 <0.01
PaCO2 [kPa] 5.6 6 0.3 5.5 6 0.5 0.17
Hemoglobin [mmol/L] 8.7 6 0.6 8.8 6 0.6 0.71
Brain weight [kg]
Body weight [kg]
Height [cm]
1.4396 0.114
81.26 8.9
187.56 7.0
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found to be very small if the artery diameter is larger than 5–6
voxels, but will cause overestimation of the flow at smaller rela-
tive diameters.38 In the present study the average diameter of
the internal carotid arteries assessed from PCM MRI measure-
ments was 7.2 voxels and of the vertebral arteries 5.6 voxels, cor-
responding to actual diameters of 5.4mm and 4.2mm,
respectively. These values are somewhat higher than the corre-
sponding values of 4.8 and 3.3mm previously reported in
young subjects using ultrasound,39 indicating a possible
overestimation of the luminal diameter due to partial volume
effect (PVE). Improving in-plane resolution may reduce the
partial volume error. Indeed, a recent in vivo study investigating
the effects of varying resolution found that PCM flow values
acquired at a resolution of 0.7mm were 13% higher in the ver-
tebral arteries and 6% higher in internal carotid arteries com-
pared to high-resolution imaging at 0.4mm.40 However,
higher-resolution imaging is associated with prolonged acquisi-
tion time and poorer SNR, and the authors of the study con-
cluded that a resolution of 0.5mm might offer a reasonable
trade-off.40
Second, a single imaging slice was used to measure veloc-
ity in all of the feeding arteries. If the slice is not perpendicular
to the vessels, linear velocities will be underestimated and the
cross-sectional area will be overestimated. Again, the two
effects will tend to balance out, and both simulation and in
vivo studies have shown that the effect on flow is negligible if
the imaging planes deviate less than 108, but will cause overes-
timation at higher degrees of deviation.38,40 The angle of mis-
alignment on each artery was measured from the angiography
images and found to be on average less than 58 on the carotid
arteries and less than 68 on the vertebral arteries. The errors
related to misalignment are therefore probably very small.
PCM MRI measurements were performed without cardi-
ac triggering in order to reduce scan time. A similar approach
has been used in several other studies.6,15,41 One previous
study has shown that nontriggered measurements produced
6% higher flow compared to triggered measurements and was
also associated with slightly poorer reproducibility.12 Other
studies, however, have not demonstrated any systematic differ-
ences.19,20,42,43 Nontriggered measurements are less susceptible
to irregular or varying heart rate and applying cardiac trigger-
ing may prolong acquisition time and potentially cause under-
estimation of flow, as the entire cardiac cycle is not sampled.
Although often considered a reference standard, the abso-
lute quantification of CBF using 15O-H2O PET is restricted
at high CBF values by the limited water diffusion across the
blood–brain barrier. The correct extraction fraction of water
depends on the exact tissue measured, the perfusion itself, and
interindividual variation, and has been suggested to be in the
range of 0.84–0.90 for average global extraction.44,45 Conse-
quently, when reporting global CBF as the K1 of the one-
tissue model, CBF is underestimated on average by 10–16%.
A further cause of global CBF PET underestimation
may be related to a partial volume effect when the low-
resolution CBF maps are masked with a high-resolution
brain mask, which leads to loss of signal in high-CBF corti-
cal voxels. White matter and cerebrospinal fluid may further
contribute to dilution of the cortical signal. A previous 15O-
H2O PET study has shown that a kinetic model incorporat-
ing a physiological correction for the segments of the ROI
that are not perfused (the nonperfusable tissue fraction) will
increase the global CBF value 17%.46
FIGURE 3: Agreement of CBF measurements. (a) Correlation
between global cerebral blood flow (CBF) measured by 15O-
H2O PET and phase-contrast mapping (PCM) MRI. (b) Bland–
Altman plot showing difference against mean of the methods.
Measurement by PCM MRI resulted in higher values compared
to 15O-H2O PET. The positive slope of the regression line of
the Bland–Altman plot was significantly different from zero
(P50.0014), indicating a perfusion-dependent relative differ-
ence between CBF values obtained by the two methods.
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The underestimations of CBF using 15O-H2O PET
due to limited water diffusion and partial volume effects are
both perfusion-dependent, causing larger underestimation at
high perfusion values. We do not expect the overestimation
of flow by PCM MRI to be flow-dependent within the nor-
mal perfusion range. The slope of the regression line being
larger than one demonstrates this perfusion-dependent
underestimation of 15O-H2O PET.
Method precision of PCM MRI as assessed by the
intrasubject coefficient was similar to a previous study that
found a corresponding value of 7.4% using a cardiac trig-
gered PCM MRI with similar resolution, also at 3T MRI.16
This finding thus confirms the very high short-term repro-
ducibility of PCM MRI for measurement of CBF, and does
not support the previous report of poorer reproducibility of
nontriggered measurements.12 The intrasubject variability of
15O-H2O PET CBF measurements was very similar to that
of PCM MRI, whereas the intersubject variability was
slightly higher using PCM MRI compared to PET. The lat-
ter observation may be a consequence of the also slightly
higher variability of PaCO2 at the MRI session.
A limitation to the present study is that 15O-H2O PET
and PCM MRI CBF measurements were not performed
simultaneously, but separated by a 2–6 hours interval. Spon-
taneous random variation in CBF could thus contribute to
method disagreement. Studies on within-subject variability in
CBF are limited and do not separate true physiological fluc-
tuations from methodological imprecision. Including also
day-to-day variability, such studies have reported overall
within-subject coefficients of variation of between 8.3% and
12.9%, but do not indicate large low-frequency variation in
CBF.18,35,47 As documented by the arterial blood gas and
hemoglobin values, the participants were studied in stable,
resting conditions at both sessions. We did observe slightly
higher PaO2 and oxygen saturation values during the PET
study compared to MRI, but these subtle differences are not
likely to influence the CBF measurements and most likely
reflect differences in blood sample handling at the two ses-
sions and in calibration of the two blood gas analyzers used.
Previous studies have shown that spontaneous fluctuations in
PaCO2 is a major source of within-subject variability
35,36 and
in the present study residual variability tended to decrease
when accounting also for changes in PaCO2.
Finally, changes in CBF and cerebral metabolism from
circadian cycle variation may also have contributed to meth-
od disagreement and residual variation.41,48 Such effects
cannot be assessed from the present study, but the awake-
state circadian changes are relatively small and cannot
account for the large offset between 15O-H2O PET and
PCM MRI CBF measurements.
The overall highly significant positive correlation of
PCM MRI with 15O-H2O PET confirms the use of PCM
MRI for absolute quantification of global CBF, and thus lends
further support for the use of PCM MRI in quantitative stud-
ies of cerebral physiology and in population-based studies of
cerebrovascular function and brain aging.6,15,40 In particular, it
allows us to more confidently interpret other quantitative
physiological MRI techniques relying on accurate measures of
global CBF obtained by PCM MRI.7,10,43 However, it should
be stressed that PET and PCM MRI measurements cannot be
used interchangeably, as the very large difference will influence
all CBF-derived physiological measures directly.
In conclusion, the present study demonstrates that
measurement of mean global CBF with PCM MRI and
15O-H2O PET are highly correlated, thereby validating the
use of PCM MRI for quantification of global CBF. The
study also showed considerable differences between the two
methods, most likely resulting from methodological biases
prohibiting interchangeable use of the methods.
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